PTPRC and cancer: On the other hand, we observed that within the CD45+ population, the frequency of NK (SSClowCD3−CD16+) cells and M1 macrophages (CD45+CD3−CD11b+CD16+HLA-DR+CD64+CD86+CD206−) was significantly lower in cancer samples than in precursor lesions.